mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
0.001 |
mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
XMD8-85 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
0.001 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.003 |